Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Baxter International Inc (BAX)

Baxter International Inc (BAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Baxter International Inc One Baxter Parkway Deerfield IL 60015 USA

www.baxter.com Employees: 38,000 P: 224-948-2000 F: 877-334-2298

Sector:

Medical

Description:

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.

Key Statistics

Overview:

Market Capitalization, $K 10,337,667
Enterprise Value, $K 21,699,668
Shares Outstanding, K 514,056
Float, K 512,977
% Float 99.79%
Short Interest, K 34,152
Short Float 6.64%
Days to Cover 4.90
Short Volume Ratio 0.69
% of Insider Shareholders 0.21%
% of Institutional Shareholders 90.19%

Financials:

Annual Sales, $ 10,636 M
Annual Net Income, $ -649,000 K
Last Quarter Sales, $ 2,835 M
Last Quarter Net Income, $ -46,000 K
EBIT, $ 280,000 K
EBITDA, $ 1,752 M

Growth:

1-Year Return -37.44%
3-Year Return -54.17%
5-Year Return -74.71%
5-Year Revenue Growth -6.39%
5-Year Earnings Growth -42.90%
5-Year Dividend Growth 22.35%

Per-Share Information:

Most Recent Earnings 0.69 on 10/30/25
Next Earnings Date 02/19/26
Earnings Per Share ttm 2.41
EPS Growth vs. Prev Qtr 16.95%
EPS Growth vs. Prev Year -13.75%
Annual Dividend & Yield (Paid) 0.52 (2.59%)
Annual Dividend & Yield (Fwd) 0.04 (0.20%)
Most Recent Dividend 0.010 on 11/28/25
Next Ex-Dividends Date 11/28/25
Dividend Payable Date 01/02/26
Dividend Payout Ratio 28.06%
Most Recent Split 46-25 on 07/01/15

BAX Ratios

Ratio
Price/Earnings ttm 8.45
Price/Earnings forward 8.67
Price/Earnings to Growth 1.17
Return-on-Equity % 17.38%
Return-on-Assets % 5.57%
Profit Margin % -6.10%
Debt/Equity 1.32
Price/Sales 0.94
Price/Cash Flow 4.23
Price/Book 1.43
Book Value/Share 14.05
Interest Coverage -0.15
60-Month Beta 0.59

BAX Dividends

Date Value
11/28/25 $0.0100
08/29/25 $0.1700
05/30/25 $0.1700
02/28/25 $0.1700
11/29/24 $0.1700
08/30/24 $0.2900
05/31/24 $0.2900
02/29/24 $0.2900
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar